#United States #New York #Class Action #Gross Law Firm #PepGen

Join the Class Action Lawsuit Against PepGen Inc.

The Gross Law Firm has recently announced a call to action for shareholders of PepGen Inc. (NASDAQ: PEPG) to participate in a class action lawsuit concerning significant concerns that have arisen about the company's operations and disclosures. Shareholders who purchased shares during the class period from March 7, 2024, to March 3, 2025, are particularly urged to get involved, as the deadline to register for participation is fast approaching on August 8, 2025.

This legal action is prompted by allegations that PepGen issued materially false or misleading statements regarding its lead product candidate, PGN-EDO51. Reports assert that the product was marketed as being both effective and safe, yet evidence has surfaced suggesting otherwise. Specific claims include that the Phase two CONNECT2 study, integral to gaining U.S. Food and Drug Administration (FDA) approval, was revealed to be dangerous and deficient. Ultimately, these revelations have led to worries that PepGen may halt the CONNECT2 study altogether, which would significantly diminish PGN-EDO51's clinical and commercial prospects.

As part of the class action process, shareholders are encouraged to contact The Gross Law Firm to discuss their eligibility for lead plaintiff status. However, it is crucial to note that while leading the lawsuit can be beneficial, it is not a requirement for participating in any potential recovery from this case. The Gross Law Firm has made registering easy through their dedicated link, ensuring that shareholders can submit their information without delay. Once registered, participants will benefit from portfolio monitoring software that provides them with updates on the case's progress.

The allegations against PepGen highlight serious concerns about corporate transparency and accountability, stressing the importance of responsible business practices. The Gross Law Firm expresses its commitment to advocating on behalf of investors who have encountered losses due to deceitful practices that inflate stock values through misinformation.

In the realm of corporate governance and investor rights, this case underscores the essential role that shareholders play in holding companies accountable for their statements and actions. By engaging in this legal process, shareholders not only seek potential restitution for their losses but also contribute to broader corporate oversight.

As the August 8 deadline approaches, now is the time for PepGen shareholders to act. Advocating for investor rights is vital in today’s business landscape, and participating in this class action is a step toward ensuring accountability in the marketplace. For more information, or to register for the class action, shareholders can visit the dedicated website provided by The Gross Law Firm.

Contact details for inquiries and registration are readily available, making it simple for shareholders to take action without incurring any costs or obligations.

Conclusion

Investors affected by the recent developments at PepGen Inc. have a critical opportunity to secure their rights and voice their concerns through this class action lawsuit. The Gross Law Firm stands ready to assist and facilitate this important endeavor for current shareholders, ensuring that they do not navigate this process alone. Don’t miss the chance to register before the upcoming deadline.